These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 10727524)

  • 1. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
    Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
    Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both ATP sites of human P-glycoprotein are essential but not symmetric.
    Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
    Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins.
    Chen G; Durán GE; Steger KA; Lacayo NJ; Jaffrézou JP; Dumontet C; Sikic BI
    J Biol Chem; 1997 Feb; 272(9):5974-82. PubMed ID: 9038218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
    Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L; Murphy GF; Béliveau R
    Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Biochemistry; 2006 Jul; 45(29):8940-51. PubMed ID: 16846237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein.
    Watanabe T; Kokubu N; Charnick SB; Naito M; Tsuruo T; Cohen D
    Br J Pharmacol; 1997 Sep; 122(2):241-8. PubMed ID: 9313931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2003 Jun; 278(23):20449-52. PubMed ID: 12711602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein.
    Urbatsch IL; Julien M; Carrier I; Rousseau ME; Cayrol R; Gros P
    Biochemistry; 2000 Nov; 39(46):14138-49. PubMed ID: 11087362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
    Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT
    Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
    Loo TW; Clarke DM
    Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores.
    Sharom FJ; DiDiodato G; Yu X; Ashbourne KJ
    J Biol Chem; 1995 Apr; 270(17):10334-41. PubMed ID: 7730340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
    Orlowski S; Mir LM; Belehradek J; Garrigos M
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed characterization of cysteine-less P-glycoprotein reveals subtle pharmacological differences in function from wild-type protein.
    Taylor AM; Storm J; Soceneantu L; Linton KJ; Gabriel M; Martin C; Woodhouse J; Blott E; Higgins CF; Callaghan R
    Br J Pharmacol; 2001 Dec; 134(8):1609-18. PubMed ID: 11739236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
    Zhang S; Morris ME
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1258-67. PubMed ID: 12604704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.